基本信息
浏览量:5
职业迁徙
个人简介
Expertise in rodent models of infectious diseases, most notably with highly pathogenic Francisella tularensis, a CDC category A pathogen. I have also worked on brucellosis, plague, and anthrax during the past few years. At NRC, I manage a vaccine development program for these pathogens. We have received ~ $10 million from NIH for our Francisella program which has led to the development of a promising new vaccine candidate that is safer and more effective than the incumbent. In 2016 DTRA granted $5.0M to a consortium, including my team, for further clinical development of this vaccine to include GMP manufacture and NHP efficacy testing with the goal of having an IND ready product within the next 5 years. In 2018 I was awarded the NRC Schneider medal for this work https://www.newswire.ca/news-releases/national-research-council-of-canada-recognizes-scientific-and-technological-achievements-702596811.html We have now licensed this vaccine to Appili Therapeutics who recently received a further $7.0M from DTRA for manufacturing and clinical trials https://financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/appili-therapeutics-announces-additional-funding-for-its-ati-1701-biodefense-program. This seemed as good a time as any to call it quits, and I formally retired from NRC in January 2020. However, I still work for them 1.5 days a week as part of their post-retirement program. I expect before too long they'll "promote" me to scientist emeritus so they won't have to pay me anything at all!
研究兴趣
论文共 125 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Marina Šantić,Anders Sjöstedt, T Resmi Henry,Jiřı́ Stulı́k, Max Maurin, Anders Johansson,J. Wayne Conlan
Frontiers research topics (2020)
引用0浏览0引用
0
0
biorxiv(2019)
Human reproduction (Oxford, England)no. 12 (2018): 2175-2183
JOURNAL OF IMMUNOLOGYno. SUP1 (2017)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn